Yeah Baby, Aquistions Daily : Roche Eyeing ALXN. In Black & White.
Source Aquisitions Daily
From Healthcare & Pharma and USA - 19 Jun 2013 07:23 UTC
Roche eyeing Alexion Pharma
The Swiss listed drugs company Roche is reported to be eyeing a bid for Alexion Pharmaceuticals. Market speculation among some investors was that Roche could pay US$130 per share for Alexion to US$150 per share